Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

CSSI Funding Opportunities

Find active funding opportunities for research programs coordinated by the Center for Strategic Scientific Initiatives (CSSI) to support research and technologies to enhance cancer detection and screening, clinical diagnosis, treatment, control, epidemiology, and health disparities.

Program Title Announcement Number Opening Date Expiration Date Activity Code
IMAT Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) RFA-CA-24-008 03/01/2024 10/02/2024 R61
IMAT Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) RFA-CA-24-009 03/01/2024 10/02/2024 R33
IMAT Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) RFA-CA-24-010 03/01/2024 10/02/2024 R61
IMAT Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) RFA-CA-24-011 03/01/2024 10/02/2024 R33
IMAT Revision Applications for Incorporation of Novel NCI-supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) RFA-CA-24-012 03/01/2024 10/02/2024 R01 (revision)
IMAT Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) RFA-CA-24-013 03/01/2024 10/02/2024 U01 (revision)
IMAT Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) RFA-CA-24-014 03/01/2024 10/02/2024 P50 (revision)
IMAT Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional) RFA-CA-24-015 03/01/2024 10/02/2024 P30 (revision)
ITCR Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) RFA-CA-24-016 05/11/2023 11/16/2024 R21
ITCR Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)  RFA-CA-24-017 05/11/2023 11/16/2024 U01
ITCR Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) RFA-CA-24-018 05/11/2023 11/16/2024 U24
ITCR Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) RFA-CA-24-019 05/11/2023 11/16/2024 U24
N/A Notice of Special Interest (NOSI): Technology Development for Cancer Control and Population Science Research NOT-CA-23-037 03/01/2023 12/31/2024 N/A
N/A Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics NOT-CA-22-083 06/14/2022 12/31/2024 N/A
  • Posted:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “CSSI Funding Opportunities was originally published by the National Cancer Institute.”

Email